Related Experiment Videos
Measuring Alzheimer's disease progression with transition probabilities: estimates from CERAD
P J Neumann1, S S Araki, A Arcelus
1Program on the Economic Evaluation of Medical Technology, Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA. pneumann@hsph.harvard.edu
Neurology
|September 26, 2001
Summary
Alzheimer's disease (AD) progresses rapidly, with male gender, younger age, and behavioral symptoms increasing the likelihood of advancing to severe stages or nursing home care. These transition probabilities vary by patient subgroup.
Area of Science:
- Gerontology
- Neuroscience
- Public Health
Background:
- Alzheimer's disease (AD) progression is complex and varies among individuals.
- Understanding disease trajectory is crucial for effective patient management and resource allocation.
- Quantifying the likelihood of moving between disease stages and care settings is essential.
Purpose of the Study:
- To estimate annual transition probabilities for Alzheimer's disease (AD) progression.
- To analyze these probabilities across different disease stages (mild, moderate, severe) and care settings (community, nursing home).
- To account for demographic factors (age, gender) and clinical characteristics (behavioral symptoms, time in stage).
Main Methods:
- Utilized data from the Consortium to Establish a Registry for Alzheimer's Disease (CERAD).
- Employed modified survival analysis and Cox proportional hazards models.
- Estimated stage-to-stage and stage-to-nursing home transition probabilities, adjusting for age, gender, and behavioral symptoms.
Main Results:
- Transition probabilities indicate rapid progression to severe AD stages and nursing home placement.
- Male gender, younger age (<65), and high behavioral symptoms correlate with higher transition probabilities.
- Disease progression rate remains relatively constant over time spent in a specific stage.
Conclusions:
- Transition probabilities offer a valuable method for characterizing Alzheimer's disease (AD) progression.
- Economic models for AD interventions must incorporate the diverse progression pathways observed in different patient subgroups.
- High levels of behavioral symptoms significantly influence AD progression and necessitate tailored management strategies.